These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12397912)

  • 21. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What do the new antimicrobials offer? Weighing the advantages and disadvantages compared with traditional agents.
    Gleckman R
    Postgrad Med; 2001 Mar; 109(3):87-91; quiz 28. PubMed ID: 11265366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neuropsychopharmacological effects of methylphenidate].
    Ikeda K; Takamatsu Y; Hagino Y; Sora I
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Jun; 29(3):121-3. PubMed ID: 19663262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

  • 25. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 26. [Medical treatments of hyperactive child: about the new pharmaceutical forms of methylphenidate marketed in France].
    Le Heuzey MF; Vergnaud S; Mouren MC
    Arch Pediatr; 2006 Jan; 13(1):100-3. PubMed ID: 16239100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linezolid resistance in coagulase-negative staphylococci.
    Kelly S; Collins J; Davin M; Gowing C; Murphy PG
    J Antimicrob Chemother; 2006 Oct; 58(4):898-9; author reply 899-900. PubMed ID: 16854956
    [No Abstract]   [Full Text] [Related]  

  • 28. Drugs for MRSA with reduced susceptibility to vancomycin.
    Med Lett Drugs Ther; 2009 May; 51(1311):36; quiz 37. PubMed ID: 19417720
    [No Abstract]   [Full Text] [Related]  

  • 29. [The use of methylphenidate in children with ADHD].
    Lauth B
    Laeknabladid; 2007 Dec; 93(12):823. PubMed ID: 18057471
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data.
    Sonuga-Barke EJ; Swanson JM; Coghill D; DeCory HH; Hatch SJ
    BMC Psychiatry; 2004 Sep; 4():28. PubMed ID: 15458569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
    Gadow KD; Sverd J
    Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
    [No Abstract]   [Full Text] [Related]  

  • 32. Case of a 67-year-old woman diagnosed with ADHD successfully treated with methylphenidate.
    da Silva MA; Louza M
    J Atten Disord; 2008 May; 11(6):623. PubMed ID: 18417727
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prolonged treatment with linezolid with good hematologic tolerability].
    Ramos A; García MJ; Blasco F; Valverde ML
    Rev Esp Quimioter; 2004 Sep; 17(3):266-7. PubMed ID: 15619657
    [No Abstract]   [Full Text] [Related]  

  • 34. FDA-approved drugs to treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2012 Mar; 50(3):11-2. PubMed ID: 22390784
    [No Abstract]   [Full Text] [Related]  

  • 35. [Off-label use: the case of methylphenidate (Ritalin)].
    Fritze J; Schmauss M
    Nervenarzt; 2002 Dec; 73(12):1210-2. PubMed ID: 12599339
    [No Abstract]   [Full Text] [Related]  

  • 36. [The course of behaviour changes in children with attention deficit and hyperactivity after drug treatment].
    Roselló B; Pitarch I; Abad L
    Rev Neurol; 2002 Feb; 34 Suppl 1():S82-90. PubMed ID: 12447796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
    Hollis CP; Thompson A
    Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylphenidate use and divorce.
    Schultz BK
    CMAJ; 2007 Sep; 177(7):751; author reply 751. PubMed ID: 17893352
    [No Abstract]   [Full Text] [Related]  

  • 39. ADHD drugs and cardiovascular risk.
    Wojnowski L
    N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729376
    [No Abstract]   [Full Text] [Related]  

  • 40. Abortion pill gets FDA approval.
    SoRelle R
    Circulation; 2000 Oct; 102(15):E9030-1. PubMed ID: 11183868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.